Choosing between TelosRX and Signos for weight loss comes down to your preferred approach: compounded GLP-1 medications with clinical oversight, or a CGM-based metabolic tracking program. TelosRX offers prescription tirzepatide and semaglutide starting from $49 per month, while Signos focuses on continuous glucose monitoring and AI-driven behavioral coaching without medications.
If you are looking for a medication-based GLP-1 program with compounded tirzepatide or semaglutide, TelosRX is the more direct path. Signos suits those who want a data-driven, medication-free approach to metabolic health using a continuous glucose monitor.
Start your intake →Quick comparison: TelosRX vs Signos
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.
What is TelosRX?
TelosRX is an online-first, LegitScript-certified telehealth pharmacy focused on GLP-1 weight management. It offers compounded tirzepatide and semaglutide, plus needle-free formats including oral tirzepatide and a microdosed tirzepatide option starting at $49 per month.
The service is fully asynchronous. You complete a short intake online, a US-licensed provider reviews it — often within hours — and approved medication ships to your door with free 48-hour delivery. No appointment is needed. You can message your care team at any time, and pricing is published upfront.
TelosRX includes quarterly labs, dose adjustments, and care-team messaging. HSA and FSA are accepted, and there are no membership fees or lock-in contracts.
What is Signos?
Signos is a metabolic health platform that pairs a continuous glucose monitor (CGM) with an AI-powered app to help users understand how food, activity, and lifestyle choices affect their blood sugar and weight. Their CGM hardware uses Dexcom sensors, and in August 2025 received FDA clearance as the first glucose monitoring system specifically indicated for weight management in people without diabetes.
Signos does not prescribe or dispense medications. Their approach is behavioral: real-time glucose data teaches users which foods cause blood sugar spikes, which the platform links to fat storage and weight gain. The program is app-driven, non-clinical, and medication-free. It raised $20 million in May 2026 — backed by Google Ventures and Dexcom — to expand its weight management platform.
Signos is a good fit for people who want to understand their metabolic health and change habits without pharmaceutical intervention. It is not a substitute for clinical weight-loss management for those who need it.
Medications: what each program offers
This is the sharpest difference between the two services. TelosRX is built around GLP-1 receptor agonists — the drug class at the center of the weight loss revolution. According to the NIH NIDDK, prescription medications for chronic weight management work best as part of a comprehensive program that includes lifestyle changes. GLP-1 and dual GIP/GLP-1 agonists like tirzepatide have demonstrated significant clinical weight loss results in trials referenced by the FDA approval announcement for tirzepatide.
TelosRX offers compounded tirzepatide and compounded semaglutide. These are not FDA-approved — they are prepared by licensed US compounding pharmacies under federal compounding regulations, and any prescription is subject to medical approval by a licensed provider.
Signos offers no medications whatsoever. Its model is founded on the idea that real-time glucose data can drive behavioral change sufficient to produce weight loss — without pharmaceuticals. This approach has merit for metabolically healthy individuals who want a data-driven lifestyle tool, but it is a fundamentally different category of service.
Key takeaway: TelosRX and Signos serve different needs. TelosRX offers compounded GLP-1 medications with clinical oversight from a LegitScript-certified pharmacy, starting at $49/mo. Signos offers a technology-first, medication-free metabolic tracking program — its genuine strength is the real-time glucose data and AI coaching for people who want to avoid medications.
Pricing and transparency
TelosRX lists every plan publicly before you sign up:
- From $49 a month — microdosed tirzepatide, 12-month plan
- $99 your first month — standard compounded tirzepatide, 12-month plan
- $145, $199, or $399 first month — 6-month, 3-month, or single-month plans
All plans include medication, free 48-hour shipping (if approved), care-team messaging, dose adjustments, and quarterly labs. HSA and FSA are accepted. There are no membership fees and no cancellation penalties.
Signos pricing is not publicly listed on their website and typically requires signup to view. The program requires purchasing CGM sensors (Dexcom hardware), which carry their own cost, in addition to any app subscription. This makes direct price comparison difficult. If medication-free metabolic tracking is what you want, Signos may be worth investigating — but budget for both the sensor hardware and the subscription.
Start your TelosRX intake to see your plan price in minutes.
How the process works
TelosRX is asynchronous from start to finish. You complete a short intake online — no appointment needed. A US-licensed provider reviews your information, typically within hours. If approved, your medication ships free with 48-hour delivery. You manage everything through the TelosRX platform: messaging, refills, lab orders, and dose adjustments.
Signos requires you to order a Dexcom CGM sensor, apply it (a small wearable on your arm), and pair it with the Signos app. The app then tracks your glucose in real time, scores your meals and activities, and provides personalized recommendations. There is no provider review or prescription involved. The onboarding is app-driven and self-directed.
For people who prefer a guided clinical path with a licensed provider involved at each step, TelosRX is the more straightforward choice. For those comfortable managing their own health data and making independent behavioral changes, Signos offers a rich self-directed platform.
Coaching and ongoing support
TelosRX provides care-team messaging throughout your program. You can ask clinical questions, request dose adjustments, and get support — all asynchronously, without scheduling a call. Quarterly labs are included to monitor your progress and flag any concerns.
Signos's support model centers on the AI app itself. The platform delivers real-time glucose scoring, personalized food and activity recommendations, and trend analysis. Signos's genuine strength here is the richness of metabolic data it provides — users gain a detailed picture of how their body responds to specific foods, sleep, stress, and exercise. This level of metabolic visibility is something TelosRX does not specifically provide.
The two approaches are complementary in concept. Some people use CGM data alongside GLP-1 therapy, though Signos and TelosRX are separate services.
Safety and medical oversight
TelosRX gates every prescription behind a licensed US provider. No medication is dispensed automatically. Providers screen for contraindications including personal or family history of medullary thyroid cancer, pancreatitis, and other conditions. Quarterly labs keep your clinical picture current. Approval is subject to medical review and is not guaranteed.
Signos involves no prescriptions and therefore no formal provider oversight. The platform is designed as a consumer wellness tool, not a clinical program. This makes it accessible and low-friction, but it means users with complex metabolic conditions or significant weight to lose may need clinical support that Signos alone cannot provide.
GLP-1 medications are not for everyone — they have real side effects, including nausea and gastrointestinal changes. A licensed provider working with TelosRX can help assess whether GLP-1 therapy is appropriate for your situation.
Which service is right for you?
Best for people who want a GLP-1 medication program with compounded tirzepatide or semaglutide, clinical oversight from a licensed provider, needle-free options, and transparent pricing — starting from $49/mo.
Best for people who want a medication-free, data-driven approach using continuous glucose monitoring and AI coaching. Signos excels at revealing how your unique metabolism responds to food and lifestyle — without any pharmaceutical intervention.
For most people seeking meaningful weight loss with clinical support, TelosRX offers the more direct path. If you want to understand your metabolic health and change behavior using real-time glucose data, Signos is a genuinely innovative platform in its category.
Frequently Asked Questions
Is TelosRX legitimate?
Yes. TelosRX is a LegitScript-certified telehealth pharmacy. Medications are compounded by licensed US compounding pharmacies, and every prescription is subject to medical approval by a licensed provider before anything ships. The service operates as an online-first, asynchronous telehealth program.
Does Signos offer GLP-1 medications like semaglutide or tirzepatide?
No. Signos does not prescribe or dispense any medications. Their platform is built around a continuous glucose monitor (CGM) paired with an AI-powered app. The service is medication-free and focused on behavioral change through metabolic data insights. If you want a GLP-1 program, you would need to look at a separate telehealth provider like TelosRX.
Are compounded GLP-1 medications FDA-approved?
No. Compounded tirzepatide and semaglutide offered by TelosRX are not FDA-approved. They are prepared by licensed US compounding pharmacies under federal compounding regulations. FDA-approved brand drugs like Wegovy and Zepbound are separate products. Any compounded prescription from TelosRX requires approval by a licensed provider, and approval is not guaranteed.
How much does TelosRX cost compared to Signos?
TelosRX publishes all pricing upfront. Plans start from $49 per month for microdosed tirzepatide on a 12-month plan, with standard tirzepatide from $99 your first month. Signos does not publicly list its pricing — costs include a Dexcom CGM sensor subscription plus the Signos app subscription. Exact Signos pricing requires signing up through their platform to view.
What makes Signos different from other weight loss programs?
Signos's defining feature is continuous glucose monitoring for weight management. In August 2025 it became the first CGM system with FDA clearance specifically for weight loss — not just diabetes management. The real-time glucose data and AI coaching help users understand which specific foods cause blood sugar spikes that drive weight gain. This metabolic visibility is Signos's core advantage over general coaching apps.
Can I do both TelosRX and Signos?
Technically yes — they are independent services. Some people combine GLP-1 medications with CGM tracking to monitor how their glucose responds during treatment. However, you would need to manage both separately, as TelosRX and Signos are not integrated platforms. Talk to your TelosRX provider about whether CGM monitoring makes sense for your situation, as approval is subject to medical review.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.